凌腾医药是一家临床阶段、研发驱动的生物制药公司，致力于开发创新型的T细胞衔接双特异性抗体药物，将恶性肿瘤转化为可控制、可治愈的疾病。通过与Horst Lindhofer博士创立的Lindis Biotech合作，凌腾医药将在授权地区和国家进一步开发卡妥索双抗的其它适应症。此外，凌腾医药正在研发下一代双特异性抗体技术平台，以更合理的药物设计、可开发性，更高的灵活性，达到个性化设计每个药物分子的目的。目前凌腾医药的产品线覆盖多种血液瘤和实体瘤。更多信息，请访问凌腾医药官网。
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
